Results for "autosomal dominant"
Conditions Encyclopedia Entry 1775298066
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1776700926
** **Mitochondrial Myopathies** are a group of rare genetic disorders characterized by muscle weakness, fatigue, and other systemic symptoms due to mutations in the mitochondrial DNA. **CONTENT:** ## Overview Mitochondrial myopathies are a diverse group of disorders that affect the mitochondria, the energy-producing structures within cells. These conditions are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various systems in the body, including the muscles, nervous system, and other organs. Symptoms can range from mild to severe and may include muscle weakness, fatigue, exercise intolerance, and other systemic symptoms. Mitochondrial myopathies are often inherited in an **autosomal dominant** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, some cases may be **sporadic**, occurring without a family history of the condition. The diagnosis of mitochondrial myopathies can be challenging, as the symptoms may be similar to those of other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to recognize the importance of mitochondrial function in muscle disease. However, it wasn't until the 1980s that the genetic basis of these conditions was fully understood. Since then, numerous studies have shed light on the molecular mechanisms underlying mitochondrial myopathies, leading to a better understanding of these complex disorders. ## Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which can affect various genes involved in energy production. Some of the most common forms of mitochondrial myopathies include: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: A condition characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: A condition characterized by muscle weakness, seizures, and ragged-red fibers in muscle biopsy. * **Kearns-Sayre syndrome (KSS)**: A condition characterized by muscle weakness, heart block, and pigmentary retinopathy. Other forms of mitochondrial myopathies include **Leigh syndrome**, **NARP syndrome**, and **Pearson syndrome**, among others. ## Significance Mitochondrial myopathies are rare but significant conditions that can have a profound impact on patients and their families. These conditions can affect various aspects of daily life, including physical function, cognitive abilities, and overall quality of life. While there is currently no cure for mitochondrial myopathies, various treatments are available to manage symptoms and improve quality of life. **Early diagnosis** and **genetic counseling** are essential for individuals and families affected by mitochondrial myopathies. Genetic testing can help identify the underlying mutation and provide a more accurate diagnosis. Support groups and online resources can also provide valuable information and emotional support for patients and their families. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first descriptions) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting muscle function and energy production **TAGS:** Mitochondrial myopathies, genetic disorders, muscle disease, energy production, mitochondrial DNA, autosomal dominant, sporadic, MELAS, MERRF, KSS, Leigh syndrome, NARP syndrome, Pearson syndrome, genetic counseling, support groups.
Health & MedicineConditions Encyclopedia Entry 1777540325
** This is an entry on a rare genetic disorder known as **Erythromelalgia**. ## Overview Erythromelalgia is a rare genetic disorder characterized by recurring episodes of burning pain, redness, and heat in the hands and feet. This condition affects approximately 1 in 200,000 people worldwide and is often misdiagnosed or underdiagnosed due to its rarity and nonspecific symptoms. Erythromelalgia can significantly impact a person's quality of life, causing discomfort, pain, and limited mobility. The symptoms of erythromelalgia can vary from person to person, but common complaints include: - **Burning pain** in the hands and feet, often triggered by heat, exercise, or stress - **Redness** and warmth in the affected areas - **Increased heart rate** and **blood pressure** in response to stress or heat - **Numbness** or **tingling** sensations in the hands and feet In some cases, erythromelalgia can be associated with other conditions, such as **migraines**, **fibromyalgia**, or **multiple sclerosis**. ## History/Background Erythromelalgia was first described in the medical literature in 1884 by a German physician named **Carl Werdin**. Initially, the condition was thought to be a variant of **Raynaud's disease**, but it was later recognized as a distinct entity. Over the years, researchers have made significant progress in understanding the genetic and molecular mechanisms underlying erythromelalgia. ## Key Information Erythromelalgia is caused by mutations in the **SCN9A** gene, which codes for a sodium channel protein involved in pain transmission. The condition is inherited in an **autosomal dominant** pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. There are two main types of erythromelalgia: - **Primary erythromelalgia**: This is the most common form of the condition, caused by mutations in the SCN9A gene. - **Secondary erythromelalgia**: This form of the condition is associated with other underlying medical conditions, such as multiple sclerosis or fibromyalgia. ## Significance Erythromelalgia is a significant condition that affects the quality of life of those affected. While there is no cure for the condition, various treatments can help manage symptoms and improve mobility. These include: - **Medications**: such as **anticonvulsants**, **antidepressants**, and **pain relievers** to manage pain and reduce symptoms - **Lifestyle modifications**: such as avoiding heat, exercising regularly, and managing stress - **Therapeutic options**: such as **cold therapy**, **physical therapy**, and **cognitive behavioral therapy** to improve mobility and manage symptoms **Early diagnosis and treatment** are crucial in managing erythromelalgia and improving quality of life. INFOBOX: - Name: Erythromelalgia - Type: Rare genetic disorder - Date: First described in 1884 - Location: Worldwide - Known For: Recurring episodes of burning pain, redness, and heat in the hands and feet TAGS: Erythromelalgia, rare genetic disorder, SCN9A gene, autosomal dominant, primary erythromelalgia, secondary erythromelalgia, pain management, quality of life, genetic disorder.
Health & MedicineConditions Encyclopedia Entry 1777218605
Mitochondrial myopathies are a group of rare genetic disorders characterized by muscle weakness, fatigue, and other symptoms caused by dysfunctional mitochondria.
Health & MedicineConditions Encyclopedia Entry 1777223416
** This article is about a rare genetic disorder known as **Erythromelalgia**, a condition characterized by burning pain, redness, and heat in the hands and feet. **CONTENT:** ### Overview Erythromelalgia is a rare genetic disorder that affects the nervous system and blood vessels. It is characterized by recurring episodes of burning pain, redness, and heat in the hands and feet. The condition is often described as feeling like walking on hot coals or having a severe sunburn. Erythromelalgia can be inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, some cases may be sporadic, meaning that they occur without a family history. People with erythromelalgia may experience a range of symptoms, including: * Burning pain in the hands and feet * Redness and heat in the affected areas * Increased sensitivity to heat and cold * Swelling and inflammation * Numbness or tingling The symptoms of erythromelalgia can be triggered by various factors, including: * Heat * Exercise * Stress * Hormonal changes * Certain medications ### History/Background Erythromelalgia was first described in the medical literature in the late 19th century. The condition was initially thought to be a rare variant of **Raynaud's disease**, a condition that affects blood flow to the fingers and toes. However, as more cases were reported, it became clear that erythromelalgia was a distinct condition with its own set of symptoms and characteristics. In the 1970s, researchers discovered that erythromelalgia was caused by mutations in the **EPO** gene, which codes for the enzyme **endothelial nitric oxide synthase** (eNOS). This enzyme plays a crucial role in regulating blood flow and blood pressure. Mutations in the EPO gene can lead to a decrease in eNOS activity, resulting in the symptoms of erythromelalgia. ### Key Information Erythromelalgia is a rare condition, affecting approximately 1 in 200,000 people. It can occur at any age, but it is most commonly diagnosed in children and young adults. The condition is often associated with other genetic disorders, including **neurofibromatosis** and **multiple endocrine neoplasia**. Treatment for erythromelalgia typically involves a combination of medications and lifestyle modifications. Medications that may be prescribed include: * **Anticonvulsants**, such as **topiramate** and **lamotrigine**, to reduce pain and inflammation * **Beta blockers**, such as **propranolol**, to reduce blood flow to the affected areas * **Antihistamines**, such as **diphenhydramine**, to reduce itching and inflammation Lifestyle modifications that may help manage erythromelalgia include: * Avoiding heat and cold * Wearing loose, comfortable clothing * Avoiding strenuous exercise * Staying hydrated ### Significance Erythromelalgia is a rare and often debilitating condition that can have a significant impact on a person's quality of life. While there is no cure for the condition, treatment can help manage symptoms and improve overall well-being. Research into the causes and treatment of erythromelalgia continues, with the goal of developing more effective treatments and improving the lives of those affected by this condition. **INFOBOX:** - Name: Erythromelalgia - Type: Rare genetic disorder - Date: First described in the late 19th century - Location: Worldwide - Known For: Recurring episodes of burning pain, redness, and heat in the hands and feet **TAGS:** Erythromelalgia, genetic disorder, rare condition, pain, redness, heat, hands, feet, nervous system, blood vessels, autosomal dominant, inherited, sporadic, Raynaud's disease, EPO gene, endothelial nitric oxide synthase, eNOS, neurofibromatosis, multiple endocrine neoplasia, anticonvulsants, beta blockers, antihistamines, lifestyle modifications.
Health & MedicineConditions Encyclopedia Entry 1780308965
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by the accumulation of mutations in the mitochondrial DNA, leading to impaired energy production and cellular dysfunction. Mitochondrial myopathies can affect various tissues and organs, including muscles, nerves, and the brain. The symptoms and severity of the disorder vary widely among individuals, depending on the specific mutation and the extent of mitochondrial damage. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is sufficient to cause the disorder. In some cases, the disorder can also be caused by **de novo** mutations, which occur spontaneously during fertilization or early embryonic development. The diagnosis of mitochondrial myopathies is often challenging, as the symptoms can be nonspecific and similar to those of other conditions. A definitive diagnosis typically requires a combination of clinical evaluation, genetic testing, and muscle biopsy. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to recognize the importance of mitochondrial function in energy production. In the 1980s, the discovery of mitochondrial DNA mutations led to a better understanding of the genetic basis of these disorders. Since then, numerous studies have shed light on the molecular mechanisms underlying mitochondrial myopathies and the development of new diagnostic and therapeutic strategies. ## Key Information Mitochondrial myopathies are characterized by a range of symptoms, including: * **Muscle weakness** and **fatigue**, particularly in the muscles of the face, arms, and legs * **Muscle pain** and **cramping** * **Numbness** and **tingling** in the hands and feet * **Vision problems**, including **blindness** and **double vision** * **Cognitive impairment** and **dementia** * **Cardiac problems**, including **heart failure** and **arrhythmias** The diagnosis of mitochondrial myopathies typically involves a combination of: * **Genetic testing**, including **DNA sequencing** and **mutation analysis** * **Muscle biopsy**, which can help identify mitochondrial damage and dysfunction * **Imaging studies**, such as **MRI** and **CT scans**, to evaluate muscle and nerve damage * **Electrophysiological studies**, such as **EMG** and **nerve conduction studies**, to assess muscle and nerve function ## Significance Mitochondrial myopathies are a significant public health concern, affecting approximately 1 in 5,000 people worldwide. The disorders are often associated with a poor prognosis, with many individuals experiencing significant disability and a reduced life expectancy. However, advances in genetic testing and diagnostic techniques have improved our ability to diagnose and manage these disorders. Researchers are also exploring new therapeutic strategies, including **gene therapy** and **mitochondrial-targeted antioxidants**, which may offer hope for the treatment and prevention of mitochondrial myopathies. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first descriptions) - Location: Worldwide - Known For: Rare genetic disorders affecting mitochondrial function **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, autosomal dominant, maternal inheritance, de novo mutations, muscle weakness, fatigue, muscle pain, numbness, tingling, vision problems, cognitive impairment, cardiac problems, genetic testing, muscle biopsy, imaging studies, electrophysiological studies.
Health & MedicineConditions Encyclopedia Entry 1780183024
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of these disorders can vary widely, but often include muscle weakness, fatigue, and other systemic problems. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. In some cases, the disorder can be caused by a new mutation in the mitochondrial DNA, which can occur spontaneously. The diagnosis of mitochondrial myopathies is often challenging, as the symptoms can be similar to those of other disorders. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ## History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers began to describe a group of disorders characterized by muscle weakness and other systemic problems. In the 1980s, researchers discovered that these disorders were caused by mutations in the mitochondrial DNA. Since then, numerous studies have been conducted to better understand the causes and effects of mitochondrial myopathies. ## Key Information Mitochondrial myopathies are a group of disorders that can be caused by mutations in the mitochondrial DNA. The most common types of mitochondrial myopathies include: * **Kearns-Sayre syndrome**: a disorder characterized by muscle weakness, heart problems, and other systemic problems. * **Myoclonic epilepsy with ragged-red fibers**: a disorder characterized by muscle weakness, seizures, and other systemic problems. * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes**: a disorder characterized by muscle weakness, seizures, and other systemic problems. Symptoms of mitochondrial myopathies can vary widely, but often include: * Muscle weakness * Fatigue * Seizures * Heart problems * Vision problems * Hearing loss * Cognitive impairment ## Significance Mitochondrial myopathies are a group of rare but serious disorders that can have a significant impact on a person's quality of life. These disorders can be challenging to diagnose and treat, and often require a multidisciplinary approach involving specialists in genetics, neurology, and other fields. Research into mitochondrial myopathies has led to a greater understanding of the role of mitochondria in human health and disease, and has paved the way for the development of new treatments and therapies. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first reported cases) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, autosomal dominant, maternal inheritance, Kearns-Sayre syndrome, myoclonic epilepsy, ragged-red fibers, mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes. **Note:** If you or a family member is experiencing symptoms of mitochondrial myopathies, it is essential to seek medical attention from a qualified healthcare professional. A diagnosis can be made through a combination of clinical evaluation, genetic testing, and muscle biopsy. Treatment options may include medications, physical therapy, and other interventions.
Health & MedicineConditions Encyclopedia Entry 1779253564
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders occur when there is a mutation in the mitochondrial DNA, which is responsible for producing energy for the cell. Mitochondrial myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of mitochondrial myopathies can vary widely, but often include muscle weakness, fatigue, and neurological problems. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the condition, and it is passed down from the mother. The disorders are relatively rare, affecting approximately 1 in 5,000 people worldwide. However, the exact prevalence of mitochondrial myopathies is difficult to determine due to the lack of a centralized registry and the varying severity of the conditions. ### History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers discovered that certain types of muscle disease were caused by mutations in the mitochondrial DNA. However, it wasn't until the 1980s that the genetic basis of these disorders was fully understood. Since then, numerous studies have been conducted to better understand the causes, symptoms, and treatment options for mitochondrial myopathies. ### Key Information Mitochondrial myopathies are a heterogeneous group of disorders, and there are several types, including: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: A disorder that affects the brain, muscles, and other organs, causing symptoms such as seizures, muscle weakness, and stroke-like episodes. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: A disorder that affects the brain and muscles, causing symptoms such as seizures, muscle weakness, and ragged-red fibers in muscle tissue. * **Kearns-Sayre syndrome (KSS)**: A disorder that affects the muscles, brain, and other organs, causing symptoms such as muscle weakness, vision loss, and heart problems. The diagnosis of mitochondrial myopathies is often challenging, as the symptoms can be similar to those of other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ### Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining overall health. The disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these conditions. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1960s (first reported cases) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, autosomal dominant, maternal inheritance, muscle weakness, fatigue, neurological problems, MELAS, MERRF, KSS, Kearns-Sayre syndrome.
Health & MedicineConditions Encyclopedia Entry 1778127065
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, nerves, and brain. The symptoms of these disorders can vary widely, but often include muscle weakness, fatigue, and pain. Mitochondrial myopathies are typically inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the disorder, and the disorder is passed down from mother to child. The disorders can also be caused by **de novo mutations**, which occur spontaneously during the formation of egg or sperm cells. ## History/Background The first description of mitochondrial myopathies dates back to the 1960s, when a group of researchers discovered a rare disorder that affected the muscles of a young woman. Since then, numerous cases have been reported, and the disorders have been classified into several subtypes based on their genetic and clinical characteristics. In the 1980s, researchers discovered that mitochondrial myopathies were caused by mutations in the mitochondrial DNA. This breakthrough led to a greater understanding of the disorders and their underlying mechanisms. Today, mitochondrial myopathies are recognized as a distinct group of disorders, and researchers continue to study their causes, symptoms, and treatment options. ## Key Information **Key Facts:** * Mitochondrial myopathies are caused by mutations in the mitochondrial DNA. * The disorders can affect various parts of the body, including the muscles, nerves, and brain. * Symptoms can vary widely, but often include muscle weakness, fatigue, and pain. * The disorders are typically inherited in an autosomal dominant or maternal inheritance pattern. * De novo mutations can also cause the disorders. **Subtypes:** * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a subtype characterized by seizures, muscle weakness, and lactic acidosis. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a subtype characterized by seizures, muscle weakness, and ragged-red fibers in muscle biopsies. * **Kearns-Sayre Syndrome (KSS)**: a subtype characterized by muscle weakness, heart block, and pigmentary retinopathy. ## Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular health. The disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these disorders. **Impact:** * Mitochondrial myopathies have led to a greater understanding of mitochondrial function and its role in human disease. * The disorders have also led to the development of new diagnostic and therapeutic strategies for mitochondrial disorders. * Research on mitochondrial myopathies has implications for the treatment of other disorders, including cancer and neurodegenerative diseases. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first description) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria TAGS: Mitochondrial myopathies, genetic disorders, mitochondrial DNA, autosomal dominant, maternal inheritance, de novo mutations, muscle weakness, fatigue, pain, MELAS, MERRF, KSS, Kearns-Sayre Syndrome.
Health & MedicineConditions Encyclopedia Entry 1777118285
** Hypertrophic Cardiomyopathy (HCM) is a genetic heart condition characterized by abnormal thickening of the heart muscle, leading to impaired heart function and increased risk of sudden cardiac death. **CONTENT:** ### Overview Hypertrophic Cardiomyopathy (HCM) is a complex and potentially life-threatening heart condition that affects approximately 1 in 500 people worldwide. It is the most common cause of sudden cardiac death in young athletes and is often associated with **arrhythmias**, **heart failure**, and **sudden cardiac arrest**. HCM is a genetic disorder that affects the heart muscle, causing it to become abnormally thickened, which can lead to impaired heart function and increased risk of complications. HCM can affect people of all ages, but it is most commonly diagnosed in young adults and children. The condition can be inherited in an **autosomal dominant** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, in some cases, HCM can occur spontaneously without a family history of the condition. ### History/Background The first descriptions of HCM date back to the 19th century, but it was not until the 1970s that the condition was fully characterized and recognized as a distinct clinical entity. In the 1980s, the discovery of the **MYBPC3** gene, which is one of the most common genes associated with HCM, marked a significant breakthrough in understanding the genetic basis of the condition. ### Key Information HCM is characterized by the following key features: * **Left ventricular hypertrophy**: Abnormal thickening of the left ventricle, which can lead to impaired heart function and increased risk of complications. * **Symptoms**: Shortness of breath, chest pain, fainting, and palpitations are common symptoms of HCM. * **Genetic basis**: HCM is caused by mutations in genes that code for proteins involved in heart muscle contraction and relaxation. * **Risk factors**: Family history, age, and certain genetic mutations increase the risk of developing HCM. * **Complications**: HCM can lead to **arrhythmias**, **heart failure**, and **sudden cardiac arrest**. ### Significance HCM is a significant public health concern due to its high prevalence and potential for serious complications. Early diagnosis and treatment can significantly improve outcomes for individuals with HCM. However, many cases of HCM remain undiagnosed, and the condition is often misdiagnosed as other heart conditions. **INFOBOX:** - Name: Hypertrophic Cardiomyopathy (HCM) - Type: Genetic heart condition - Date: 1970s (first descriptions), 1980s (discovery of MYBPC3 gene) - Location: Worldwide - Known For: Most common cause of sudden cardiac death in young athletes **TAGS:** Hypertrophic Cardiomyopathy, HCM, genetic heart condition, arrhythmias, heart failure, sudden cardiac arrest, autosomal dominant, MYBPC3 gene, left ventricular hypertrophy, cardiac complications.
Health & MedicineConditions Encyclopedia Entry 1777226233
** This encyclopedia entry is about a rare genetic disorder known as **Erythromelalgia** (EM), a condition characterized by burning pain, heat, and redness in the hands and feet. **CONTENT** ### Overview Erythromelalgia (EM) is a rare genetic disorder that affects the nerves and blood vessels in the hands and feet. It is characterized by recurring episodes of burning pain, heat, and redness in these areas. The condition is often described as feeling like walking on hot coals or having a severe sunburn. Erythromelalgia can be a chronic and debilitating condition, significantly impacting a person's quality of life. The symptoms of EM can vary in severity and frequency, but they often worsen with temperature changes, physical activity, or stress. Some people may experience mild symptoms, while others may experience severe and debilitating pain. In severe cases, EM can lead to skin ulcers, nerve damage, and other complications. ### History/Background Erythromelalgia was first described in the medical literature in the late 19th century. The condition was initially thought to be a rare variant of **Raynaud's disease**, a condition that affects blood flow to the fingers and toes. However, as more cases were reported, it became clear that EM was a distinct condition with its own set of symptoms and characteristics. In the 1960s and 1970s, researchers began to identify the genetic basis of EM. They discovered that the condition was caused by mutations in the **SCN9A** gene, which codes for a sodium channel protein involved in nerve function. This discovery led to a greater understanding of the condition and the development of new treatments. ### Key Information Erythromelalgia is a rare condition, affecting approximately 1 in 200,000 people worldwide. It can occur at any age, but it is most commonly diagnosed in children and young adults. The condition is often inherited in an **autosomal dominant** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. There are two main types of EM: primary and secondary. Primary EM is caused by a genetic mutation, while secondary EM is caused by an underlying medical condition, such as **multiple sclerosis** or **diabetes**. ### Significance Erythromelalgia is a significant condition because it can have a profound impact on a person's quality of life. The chronic pain and discomfort associated with EM can lead to depression, anxiety, and other mental health issues. In addition, the condition can make it difficult to engage in physical activity, work, or participate in social activities. Research into EM has also led to a greater understanding of the underlying biology of pain and nerve function. This knowledge has implications for the treatment of other conditions, such as **neuropathic pain** and **epilepsy**. **INFOBOX:** - **Name:** Erythromelalgia (EM) - **Type:** Rare genetic disorder - **Date:** First described in the late 19th century - **Location:** Worldwide - **Known For:** Chronic pain, heat, and redness in the hands and feet **TAGS:** Erythromelalgia, genetic disorder, rare condition, chronic pain, heat, redness, hands, feet, SCN9A gene, autosomal dominant, primary EM, secondary EM, multiple sclerosis, diabetes, neuropathic pain, epilepsy.
Health & MedicineConditions Encyclopedia Entry 1778564164
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by the accumulation of mutations in the mitochondrial DNA, which disrupts the normal functioning of the mitochondria. As a result, cells are unable to produce enough energy, leading to a range of symptoms and complications. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. This is because mitochondrial DNA is passed down from mother to child, and a single mutation can be inherited by all offspring. The symptoms of mitochondrial myopathies can vary widely, depending on the specific mutation and the affected individual. ## History/Background The first cases of mitochondrial myopathies were reported in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. In 1988, a team of scientists led by Dr. Doug Wallace discovered that mitochondrial myopathies were caused by mutations in the mitochondrial DNA. This breakthrough led to a greater understanding of the role of mitochondria in human disease and paved the way for the development of new treatments. ## Key Information Mitochondrial myopathies are characterized by a range of symptoms, including: * **Muscle weakness**: Muscle weakness is a common symptom of mitochondrial myopathies, particularly in the muscles of the face, arms, and legs. * **Fatigue**: Fatigue is a hallmark symptom of mitochondrial myopathies, as cells are unable to produce enough energy to support normal bodily functions. * **Neurological symptoms**: Some individuals with mitochondrial myopathies may experience neurological symptoms, such as seizures, tremors, and vision loss. * **Developmental delays**: Children with mitochondrial myopathies may experience developmental delays, including delayed speech and motor skills. There is currently no cure for mitochondrial myopathies, but various treatments can help manage symptoms and slow disease progression. These include: * **Palliative care**: Palliative care focuses on relieving symptoms and improving quality of life. * **Physical therapy**: Physical therapy can help improve muscle strength and mobility. * **Speech therapy**: Speech therapy can help individuals with mitochondrial myopathies improve communication skills. * **Genetic counseling**: Genetic counseling can help individuals and families understand the risks of inheriting mitochondrial myopathies. ## Significance Mitochondrial myopathies are relatively rare, affecting approximately 1 in 5,000 individuals worldwide. However, these disorders have significant implications for individuals and families affected by them. Mitochondrial myopathies highlight the importance of understanding the genetic basis of human disease and the need for targeted treatments. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1988 (discovery of genetic basis) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorder, mitochondrial DNA, autosomal dominant, maternal inheritance, muscle weakness, fatigue, neurological symptoms, developmental delays, palliative care, physical therapy, speech therapy, genetic counseling.
Health & MedicineConditions Encyclopedia Entry 1781279167
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial Myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of Mitochondrial Myopathies can vary widely, but often include muscle weakness, fatigue, and other systemic problems. Mitochondrial Myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. In some cases, the condition can be caused by a new mutation in the mitochondrial DNA. The diagnosis of Mitochondrial Myopathies is often challenging, as the symptoms can be similar to those of other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ## History/Background Mitochondrial Myopathies were first described in the 1960s, but it wasn't until the 1980s that the genetic basis of the condition was understood. In 1988, a team of researchers led by Dr. Douglas C. Wallace discovered that Mitochondrial Myopathies were caused by mutations in the mitochondrial DNA. This discovery led to a greater understanding of the role of mitochondria in cellular energy production and the development of new treatments for the condition. ## Key Information Mitochondrial Myopathies are a group of disorders that affect the mitochondria, the energy-producing structures within cells. The most common types of Mitochondrial Myopathies include: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a condition characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a condition characterized by muscle weakness, seizures, and ragged-red fibers in muscle tissue. * **Kearns-Sayre Syndrome (KSS)**: a condition characterized by muscle weakness, heart problems, and vision loss. The symptoms of Mitochondrial Myopathies can vary widely, but often include: * Muscle weakness * Fatigue * Headaches * Seizures * Vision loss * Hearing loss * Heart problems ## Significance Mitochondrial Myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are often inherited and can have a significant impact on an individual's quality of life. While there is currently no cure for Mitochondrial Myopathies, various treatments are available to manage the symptoms and slow the progression of the condition. ## InfoBox: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first described), 1988 (genetic basis understood) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria ## Tags: Mitochondrial Myopathies, genetic disorder, mitochondrial DNA, autosomal dominant, maternal inheritance, MELAS, MERRF, KSS, muscle weakness, fatigue, seizures, vision loss, heart problems.
Health & MedicineConditions Encyclopedia Entry 1781586365
** This article provides a comprehensive overview of **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the primary source of energy for cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders characterized by the impaired functioning of the mitochondria, the energy-producing structures within cells. These disorders affect various tissues, particularly muscle cells, leading to a range of symptoms, including muscle weakness, fatigue, and pain. MM are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. This unique genetic makeup makes MM distinct from other myopathies, such as muscular dystrophy, which are caused by mutations in nuclear DNA. Mitochondrial Myopathies are often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. However, some cases may be caused by spontaneous mutations or may be inherited in an autosomal recessive pattern. The symptoms of MM can vary widely, even among individuals with the same genetic mutation. Some common symptoms include exercise intolerance, muscle weakness, particularly in the muscles of the face, arms, and legs, and muscle pain or cramping. ### History/Background The first reported cases of Mitochondrial Myopathies date back to the 1960s, when researchers began to identify the unique genetic characteristics of these disorders. In the 1980s, the discovery of the mitochondrial DNA and its role in energy production revolutionized our understanding of MM. Since then, numerous studies have shed light on the genetic and molecular mechanisms underlying these disorders. Key milestones in the history of MM research include: * 1960s: First reported cases of MM * 1980s: Discovery of mitochondrial DNA and its role in energy production * 1990s: Identification of the first mitochondrial DNA mutations associated with MM * 2000s: Development of genetic testing for MM ### Key Information Mitochondrial Myopathies are characterized by several key features: * **Genetic mutations**: Mutations in the mitochondrial DNA, which are separate from the DNA found in the cell's nucleus * **Energy production**: Impaired energy production in muscle cells, leading to symptoms such as muscle weakness and fatigue * **Inheritance**: Autosomal dominant or autosomal recessive inheritance patterns * **Symptoms**: Varying symptoms, including exercise intolerance, muscle weakness, and muscle pain or cramping * **Treatment**: No cure, but various treatments can help manage symptoms, including physical therapy, medication, and lifestyle modifications ### Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular health. These disorders also underscore the complexity of genetic inheritance and the need for accurate genetic testing. Furthermore, MM research has led to a greater understanding of the molecular mechanisms underlying energy production and has implications for the development of new treatments for a range of diseases. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first reported cases) - Location: Worldwide - Known For: Unique genetic characteristics and impaired energy production in muscle cells **TAGS:** Mitochondrial Myopathies, genetic disorder, mitochondrial DNA, energy production, muscle weakness, fatigue, muscle pain, cramping, exercise intolerance, autosomal dominant, autosomal recessive, genetic testing, physical therapy, medication, lifestyle modifications.